In terms of regulation of CD4+ T cells, JKAP is reported to repress CD4+ T‐cell activation as well as its differentiation into Th1 and Th17 cells in systemic lupus erythematosus nephritis and inflammatory bowel disease.12, 13. Here, DUSP22 is linked to inflammatory bowel disease.